!!Anna Dominiczak - Curriculum Vitae
\\
__Current Post:__ Regius Chair of Medicine, University of Glasgow; Director of Laboratories and SRO, Rosalind Franklin Laboratory, NHS Test & Trace, Department of Health & Social Care, UK Government; Honorary Consultant Physician and Endocrinologist, Greater Glasgow and Clyde Health Board; and Health Innovation Champion for the Medical Research Council\\
\\
Researcher ID: P-9390-2017 Orcid ID: 0000-0003-4913-3608\\
\\
__Degrees & Honours:__
\\
*1978 MD Honours, Medical School, Gdansk, Poland\\
*1986 MRCP (UK)\\
*1989 MD University of Glasgow - Thesis: “Platelet cytosolic free calcium and echocardiographic ventricular mass in essential hypertension and left primary hyperparathyroidism” \\
*1995 FRCP (Glasgow, London, Edinburgh)
*2005 O.B.E. for services to medicine
*2016 D.B.E. for services to cardiovascular and medical sciences
*2016 Honorary Degree, Doctor of Science, Glasgow Caledonian University
*2018 Honorary Degree, Doctor of Science, University of Aberdeen
\\
__Academic Distinctions and Awards:__
\\
*International Fellowship of the American Heart Association (F.A.H.A.) 1996\\
*FMedSci (Fellowship of the Academy of Medical Sciences) 2001\\
*FRSE (Fellowship of the Royal Society of Edinburgh) 2003\\
*The Lecturer of the Year, Belgian Hypertension Society  2003\\
*Presidential Award and Lecture, Canadian Hypertension Society 2003\\
*Arthur Corcoran Award and Lecture, American Heart Association 2004\\
*RD Wright Award and Lecture, High Blood Pressure Research, Council of Australia 2005\\
*The Lord Provost’s Special Award for contribution and commitment to the Health of Glasgow 2007\\
*Scotswoman of the Year 2007\\
*Bjorn Folkow Award and Lecture, European Society of Hypertension 2008\\
*Fellowship of the European Society of Cardiology  2008\\
*The Graham Lecture and Medal, The Royal Philosophical Society of Glasgow  2009\\
*Sackler Fellowship and Lecture, Tel Aviv   2010\\
*Fellowship of the Society of Biology  2010\\
*The William Harvey Outstanding Contribution to Science Award and Lecture, London  2013\\
*The Robert Tigerstedt Award and Lecture, Helsinki 2014\\
*Visiting Professorship, Sun Yat Sen University, Guangzhou, China  2015\\
*Visiting Professorship, Chinese University of Hong Kong  2016\\
*The Pickering Lecture, British and Irish Hypertension Society  2017\\
*Sir Derrick Melville Dunlop Lecture, Royal College of Physicians, Edinburgh  2018\\
*Fitzgerald Peel Lecture, Scottish Society of Physicians  2019\\
*Advisory Professor of Shanghai Jiao Tong University School of Medicine  2019\\
*Distinguished Achievement Award at Hypertension 2020 Scientific Sessions  2020\\
*Fellowship of the Association of Physicians of Great Britain & Ireland   2021
\\
__Posts Held:__
\\
*Director of Laboratories, NHS Test & Trace, Department of Health & Social Care, UK Government 2020   \\
*Health Innovation Champion, Medical Research Council 2019 \\
*Vice Principal and Head of College of Medical, Veterinary and Life Sciences 2010 - 2020\\
*Head of Division of Cardiovascular and Medical Sciences 2008 - 2010\\
*Associate Dean for Research, Faculty of Medicine 2003 - 2010\\
*Director, BHF Glasgow Cardiovascular Research Centre                                                                         2001 - 2010\\
*BHF Professor of Cardiovascular Medicine                                                                                              1998 - 2010\\
*1997 Professor of Cardiovascular Medicine, Personal Chair, University of Glasgow \\
*Senior Lecturer and Reader in Medicine and Honorary Consultant  1993 - 1996\\
*Physician and Endocrinologist, University of Glasgow \\
*British Heart Foundation Senior Research Fellow  1993 - 1998\\
*Clinical Lecturer and Honorary Senior Registrar in Medicine and Endocrinology,  1992 - 1993\\
*Department of Medicine and Therapeutics, University of Glasgow
\\
__Membership of Professional Societies:__
\\
*British Medical Association 1983\\
*Scottish Society of Experimental Medicine 1988 \\
*British Hypertension Society 1989 - \\
*International Society of Hypertension 1991\\
*European Society of Hypertension 1992\\
*Caledonian Society for Endocrinology 1992\\
*British Endocrine Society 1994 \\
*Scottish Society of Physicians 1995 \\
*Association of Physicians of Great Britain and Ireland 1997 \\
*American Physiological Society 1998 \\
*British Atherosclerosis Society  2003\\
*Honorary Life Member, High Blood Pressure Research Council of Australia 2005\\
*Honorary Life Member, Polish Hypertension Society 2005 \\
*British Cardiovascular Society  2006 \\
*European Atherosclerosis Society 2012
\\
__Executive Roles in Professional Societies:__
\\
*Scottish Society of Experimental Medicine  -  Council Member  1992 - 2001, Secretary 1998 - 2001\\
*International Society of Hypertension  -  Member of the Scientific Council 1998 - 2000,  Member at Large of Scientific Council 2000 - 2002, Secretary of the Society 2002 - 2006\\
*British Hypertension Society -  Member of the Executive Committee 1999 - 2002\\
*European Society of Hypertension  -  Member of the Scientific Council 2002 - 2009, Member at Large of Scientific Council  2009 - 2011, Vice President of Scientific Council 2011 - 2013, President of the ESH 2013 - 2015\\
*American Heart Association  -  Member, Publication Committee 2002 - 2007, Member, Membership Committee 2003 - 2008, Member, International Membership Task Force 2005 - 2007, Member, Awards Committee 2007 - 2010, Member, Leadership Committee  2010 \\
*Association of Physicians of Great Britain  - President Elect & President  2018 - 2021 and Ireland\\
*National/International Research Committees & Advisory Boards\\
*Member, Chief Scientist Office Advisory Group on Cardiovascular Disease and Stroke 2002 - 2007\\
*Member, Royal Society of Edinburgh, International Committee 2004 - 2008\\
*Member, Royal Society of Edinburgh, Research Fellowship Committee 2005 - 2007\\
*Chair, Royal Society of Edinburgh, Sectional Committee  2007 - 2009\\
*Member, Council, Royal Society of Edinburgh 2009 - 2015\\
*Member, Research Assessment Exercise 2008, Cardiovascular Sub-panel 2005 - 2008\\
*Member, Wellcome Trust Physiological Sciences Funding Committee 2005 - 2008\\
*Member, Foundation Leducq, Scientific Advisory Committee (Vice President 2009-2011) 2006 - 2011\\
*Member, Max-Delbrück Centre for Molecular Medicine (MDC) Scientific Advisory Board 2007 - 2016 \\
*Member, George Pompidou European Hospital (HEGP) Paris Scientific Advisory Board 2007 \\
*Member, MRC Clinical Training & Career Development Panel 2010 - 2012\\
*Member, Medical Schools Council   2010 - 2020\\
*Member, Board for Academic Medicine (Scotland)  2010 - 2020\\
*Member, Health Committee, Universities Scotland  2011 - 2013\\
*Member, Health Science Scotland Oversight Board 2011 - 2018\\
*Member, Council of the Academy of Medical Sciences 2012 - 2014\\
*Vice President, Life Sciences, Royal Society of Edinburgh      2012 - 2015\\
*Member, Research Excellence Framework, Clinical Medicine Panel 2013 - 2014\\
*Member, MRC Stratified Medicine Panel  2013 - 2018\\
*Trustee, British Heart Foundation, Board of Trustees 2014 - 2020\\
*Chair, MRC Translational Research Group  2016\\
*Member, MRC Strategy Board  2016\\
*Member, Medical Schools Council Executive   2016 - 2020\\
*Chair, Equality & Diversity Working Group, Medical, Dental & Veterinary School Councils  2016 - 2018\\
*Member, Research Excellence Framework Main Panel A (interdisciplinary role) 2018 - 2021\\
*Member of the Council, Academy of Medical Sciences 2018\\
*Member of the Scottish Science Advisory Committee 2018\\
*Scientific Advisory Board, Monash University, Australia 2018 \\
*Member, Health and Social Care Innovation Steering Group 2020 - 2023\\
*National Institute of Health Research / NHS England/Improvement –  2020\\
*Academic Health Science Centre Competition\\
*Chair, International Scientific Council at the Medical University of Gdansk 2020\\
*Chair, UKRI Living Laboratory Programme Scientific Steering Group 2020\\
*Member, UKRI Living Laboratory (SIPF) Governance Committee 2020 \\
*Academy of Medical Sciences, Academy’s FORUM Advisory Group 2021 \\
*NIHR Biomedical Research Centre International Selection Committee 2021 - 2022\\
*Chair, Pharmacogenomics Informed Medication Management Project Programme Board 2021
\\
__Editorial Work:__
\\
*Editor in Chief - Hypertension (Journal of the American Heart Association)  2012 - 2022\\
*Consulting Editor - Hypertension Research 2012 \\
*Associate Editor - Journal of Hypertension 2009 - 2012\\
*Editor in Chief - Clinical Science 2004 - 2008
\\
__Editorial Board Member:__
\\
*Journal of Hypertension 1994\\
*Hypertension 1998 \\
*Physiological Genomics 1999 \\
*Blood Pressure 2001\\
*Cell Metabolism  2004 \\
*Current Hypertension Reviews 2004 \\
*American Journal of Hypertension 2006\\
*Internal and Emergency Medicine 2006\\
*Journal of the American Society of Hypertension 2006 \\
*The Asia-Pacific Journal of General Practice  2009 \\
*Global Heart 2011 \\
*Arterial Hypertension 2015
\\
__Major Research Grants and Infrastructure Awards:__
\\
*British Heart Foundation Tenure Amount\\
*4 x BHF Programme Grants 1999 - 2014  £4,098,853\\
*3 x BHF Infrastructure Awards 2000-2009 £7,469,790\\
*BHF 4 Year PhD Programme 2009 - 2016 £1,971,768\\
*Medical Research Council\\
*The MRC British genetics of hypertension (BRIGHT) study: 2003 - 2008 £1,917,104, grant number G9521010 (with Profs Caulfield, Benjamin, Brown, Clayton, Connell, Dominiczak, Lathrop, and Samani and Drs Farrall, Munroe and Webster).\\
*United Kingdom collaborative study to identify major genes 1996 - 2003 £2,156,734 responsible for human essential hypertension. Programme Grant with representatives of 4 other major centres within the UK. \\
*United Kingdom collaborative study - establishment of a 1999 - 2003 £770,193 transmission disequilibrium testing resource for fine mapping within the MRC British Genetics of Hypertension (with Prof Mark Caulfield & representatives of 4 other major centres within the UK).\\
*University of Glasgow Confidence in Concept 2013 2014 - 2015 £500,000\\
*Imaging Centre of Excellence 2015 - 2017 £16,000,000\\
*Glasgow Molecular Pathology (GMP) Node 2015 - 2018 £3,429,806\\
*Priming Innovative Translational Research - The Glasgow  2016-2017 £500,000\\
*Chemical Biology Programme\\
*Accelerating Precision Diagnostics - Bridging the Gap 2017 - 2019 £280,000\\
*Capital Award - Contribution to Institute of Health & Wellbeing building 2017 - 2019 £7,500,000\\
*Glasgow Precision Diagnostics & Therapeutics - Confidence in Concept 2018 - 2020 £413,000\\
*University of Glasgow Confidence in Concept 2019 & 2020 2019 - 2022 £898,200\\
*UKRI Strength in Places Fund - The Living Laboratory  2020 - 2025 £91,000,000\\
*(£38m + matched funding from consortium partners of £53m)\\
*Wellcome Trust    \\
*Cardiovascular Functional Genomics: translating experimental work to 2002 - 2009 £5,300,000 human disease (with Prof N Samani & representatives of 3 other centres).\\
*WTCCC3 core activities (with Prof Leena Peltonen, Dr Linda Morgan 2009 - 2011 £4,513,859 & other consortium members).\\
*Institutional Strategic Support Fund (ISSF1, ISSF2, ISSF3) 2011 - 2019 £7,500,000\\
*Glasgow CRF: translating research into benefits for patients 2015 £750,000\\
*2 x Institutional Translational Partnership Awards 2019 - 2022 £1,400,000\\
*Institutional Strategic Support Fund 2019 - 2021 £1,500,000\\
*The Wolfson Foundation\\
*Glasgow Clinical Research Facility 2012 - 2013 £850,000\\
*The Dr Mortimer and Theresa Sackler Foundation\\
*Glasgow Clinical Research Facility and Imaging Research Facility 2014 - 2016 £3,500,000\\
*Scottish Funding Council \\
*University of Glasgow component (joint with Dr D Blackbourn) of 2001 - 2003 £335,000\\
*£2.2M to establish Scottish Centre for Genomic Microarray Technology \\
*Genetic Health in the 21st Century Project. 2004 - 2007 £247,268 \\
*Biomarkers for battling chronic diseases 2007 - 2012 £1,211,355 (with Profs W Kolch, D Porteous, A Morris and B. Smith).\\
*Stratified Medicine Scotland Innovation Centre. 2012 - 2017  £8,000,000\\
*Additional funding to support location of Stratified Medicine Scotland 2012 - 2013  £5,000,000\\
*Innovation Centre at Queen Elizabeth University Hospital, Glasgow.\\
*Leader Skills Development 2018 - 2019         £107,239\\
*SMS-IC Maintenance Contract 2019 - 2020         £413,772\\
*Scottish Executive Health Department\\
*Scottish Ecosystem for Precision Medicine  2016 - 2017 £4,000,000\\
*Scottish Enterprise\\
*Stratified Medicine Scotland Innovation Centre (phase 2) 2019 - 2024 £2,000,000\\
*Chief Scientist Office \\
*Generation Scotland-Genetics and Healthcare Initiative 2005 - 2009  £4,300,000 Total (with Prof A Morris, Prof D Porteous and Dr B Smith)  £1,355,306 Glasgow\\
*Generation Scotland - continuation of Genetics and 2008 - 2011 £3,870,000 Total\\
*Healthcare Initiative (same co-PIs as above).  £1,049,157 Glasgow\\
*The Precision Medicine Ecosystem. 2016-2017 £3,480,000\\
*Hypertension, inhibitors of the renin angiotensin system and COVID-19  2020 £76,846\\
*Science Research Investment Fund 2 (SRIF2) Programme\\
*Funding for GCRC/GBRC Research Centres (with Profs Liew & Kolch) 2004 - 2006  £1,200,000\\
*UK Government Department of Health & Social Care\\
*The Lighthouse Laboratory 2020 £16,974,229\\
*Eluceda\\
*Validation-diagnostic COVID-19 test Eluceda 2020 £16,672\\
*European Community\\
*EURNETGEN - Shared costs project with representatives of 4 2000 - 2003 €1,300,000   Total other countries (coordinator).  £239,743     Glasgow\\
*EURATools - European Rat Tools for Functional Genomics: 2006 - 2010 €3,900,000   Total multicentre award (coordinator Prof T Aitman).  £377,334    Glasgow\\
*INGenious HyperCare - Integrating Genomics, Clinical Research &  2007 - 2011 €18,199,947 Total\\
*Care in Hypertension; multicentre award (coordinator Prof A Zanchetti)  £896,785    Glasgow\\
*EURATrans - European large-scale functional genomics in the 2009 - 2014 €10,500,000 Total rate for translational research (coordinator Norbert Hübner). £303,499      Glasgow\\
*EU-MASCARA - MArkers for Subclinical CArdiovascular 2011 - 2015 €6,000,000   Total Risk Assessment (coordinator)  £1,019,256   Glasgow\\
*EU-InterPregGen - Genetic studies of pre-eclampsia in Central  2011 - 2016 €5,000,000   Total   \\
*Asian and European populations  £178,984  \\ \\